[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338245-105":59,"doc-detail-338245-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pancreatic-cancer-arising-in-intraductal-papillary-mucinous-neoplasms-ipmn-emerging-data-warrants-further-research-editorial","Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research - Editorial","","Editorial分析胰腺导管内乳头状黏液性肿瘤（IPMN）相关癌变的关键证据与研究方向。文中指出：绝大多数IPMN不发展为侵袭癌，但约20%经手术切除的病例在病理中可见侵袭成分，WHO将其称为由IPMN发生的腺癌（A-IPMN）。A-IPMN预后取决于侵袭成分；不同上皮亚型与肿瘤形态学相关，非肠型更易出现血管/淋巴侵犯与淋巴结转移。并讨论罕见的IOPN作为独立实体的侵袭性表现，以及A-IPMN术后复发模式、复发风险病理因素与复发治疗的证据不足，强调需要进一步研究与更优系统治疗策略。",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pancreatic-cancer-arising-in-intraductal-papillary-mucinous-neoplasms-ipmn-emerging-data-warrants-further-research-editorial/338245/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pancreatic-cancer-arising-in-intraductal-papillary-mucinous-neoplasms-ipmn-emerging-data-warrants-further-research-editorial/338245.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"IPMN相关的侵袭癌在最新WHO分类中如何命名？","Question",{"text":112,"@type":113},"当IPMN伴随腺癌成分时，文中指出按最新WHO指南称为由IPMN发生的腺癌（A-IPMN）。","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"A-IPMN预后最关键的决定因素是什么？",{"text":117,"@type":113},"文中强调，与IPMN相关的伴随腺癌成分是手术切除后生存结局的单一最关键决定因素。",{"name":119,"@type":110,"acceptedAnswer":120},"A-IPMN术后复发的频率与主要影响因素有哪些？",{"text":121,"@type":113},"文中指出总体约近一半患者复发，且约五分之一在术后第一年内复发；复发风险由分化程度、淋巴结状态以及是否需要多脏器切除等病理特征决定。","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338245,1791249331,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":81,"preview_urls":144},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","BJS, 2024, znae238  \n[https://doi.org/10.1093/bjs/znae238](https://doi.org/10.1093/bjs/znae238)  \nEditorial  \nPancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research  \nJames Lucocq1  and Sanjay Pandanaboyana2,*   \n1Department of Hepatopancreatobiliary Surgery, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK 2Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle, UK  \n*Correspondence to: Sanjay Pandanaboyana, Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK  \n(e-mail: [s.pandanaboyana@nhs.net](s.pandanaboyana@nhs.net))  \nIntraductal papillary mucinous neoplasms (IPMNs) are the most frequent cystic lesions of the pancreas and are considered a premalignant condition. The vast majority of IPMNs never develop into invasive cancer, but around 20% of resected IPMNs are found to harbour an invasive component on histopathological examination. This type of pancreatic cancer is now termed adenocarcinoma arising from IPMN (A-IPMN) according to the latest WHO guidelines1. The presence of an associated adenocarcinoma in IPMNs is the single most crucial determinant of survival outcome following surgical resection for IPMN. Even in those A-IPMNs that proceed to surgical resection, the prognosis for A-IPMN remains poor, with only about one-third of patients achieving disease-free survival at 5 years post-resection2.  \nA-IPMNs themselves are a heterogeneous group of tumours that are characterized by various defining elements (for example, precursor epithelial subtype, invasive component and lesion location), each of which could influence the clinical behaviour and carry prognostic implications. In patients with A-IPMN, understanding what drives the biological progression from the precursor epithelial lesion to invasive adenocarcinoma is key to predicting survival and oncological outcomes. Non-intestinal subtypes (gastric and pancreatobiliary) are more likely to exhibit lymphovascular invasion, lymph node involvement and have advanced disease at the time of resection than the intestinal subtype counterpart. It follows that long-term oncological outcomes of gastric and pancreatobilary subtypes are comparable but both subtypes in general experience inferior outcomes compared to that of the intestinal subtype. Mixed subtypes are present in approximately 20% of resected A-IPMN specimens and the prognosis tends to align with the more aggressive non-intestinal constituent subtype3.  \nA strong association between the precursor epithelial subtype and invasive component has been found. Non-intestinal subtypes are prone to develop the more invasive ductal adenocarcinoma, whereas the intestinal subtype has a propensity towards the more indolent colloid carcinoma3. Interestingly, the relationship between precursor epithelial subtype and the type of carcinoma is  \nnot absolute and although infrequent, a non-intestinal precursor may evolve into colloid carcinoma, and intestinal subtypes to ductal carcinoma. Multivariable analysis suggests that survival and oncological outcomes are directed by the invasive component (for example, ductal versus colloid carcinoma) instead of the underlying initial precursor subtype3. The underpinning molecular drivers of the morphological findings should hence be explored to better detail the biological mechanisms behind this.  \nA rarely found pancreatic lesion is the intraductal oncocytic papillary mucinous neoplasms (IOPNs), reported to be approximately 10–20 times less common than IPMNs4. Although a former IPMN subtype, the 2020 WHO classification now recognizes IOPNs as a distinct entity based on their unique morphological and genetic characteristics4. Despite limited evidence in the literature, recent data found that invasive IOPNs are in fact aggressive lesions that follow a clinical course consistent with pancreatic ductal adenocarcinoma with inferior survival outcomes compared to colloid carcinoma","cbCailPSuOk0aSx9","https://ap.wps.com/l/cbCailPSuOk0aSx9","pdf",122755,"English","# Editorial\n## IPMN到侵袭癌（A-IPMN）的发生与预后\n## 上皮亚型与侵袭成分的生物学驱动\n## IO P N 的独立地位与侵袭性证据\n## A-IPMN术后复发模式与复发风险因素","[{\"question\":\"IPMN相关的侵袭癌在最新WHO分类中如何命名？\",\"answer\":\"当IPMN伴随腺癌成分时，文中指出按最新WHO指南称为由IPMN发生的腺癌（A-IPMN）。\"},{\"question\":\"A-IPMN预后最关键的决定因素是什么？\",\"answer\":\"文中强调，与IPMN相关的伴随腺癌成分是手术切除后生存结局的单一最关键决定因素。\"},{\"question\":\"A-IPMN术后复发的频率与主要影响因素有哪些？\",\"answer\":\"文中指出总体约近一半患者复发，且约五分之一在术后第一年内复发；复发风险由分化程度、淋巴结状态以及是否需要多脏器切除等病理特征决定。\"}]","Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research - Editorial | PDF",1790022725,[145,149,153],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afc643f797c00f4efcf1cc2756f04986.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/400ccd3e4de425ee551bfefc8b37b9c5.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/337201103f8004c6db6935348797b3c5.webp",981,1289]